Resilience

Resilience is a leading biomanufacturing innovation company focused on the development of novel medicines. Specializing in the manufacturing of complex medicines such as cell and gene therapies, Resilience partners with small and mid-sized biotech firms to provide customized solutions that leverage cutting-edge technologies and scientific advancement. Their approach includes high-tech, end-to-end drug substance and drug product manufacturing capabilities aimed at ensuring rapid, safe, and scalable production. Resilience operates primarily in North America, with expertise in delivering regulatory-compliant solutions across global markets, enhancing the reliability and accessibility of biopharmaceutical supply chains.